Form 8-K - Current report:
SEC Accession No. 0001493152-23-024277
Filing Date
2023-07-12
Accepted
2023-07-11 18:35:04
Documents
28
Period of Report
2023-06-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48942
2 ex4-1.htm EX-4.1 111623
3 ex4-2.htm EX-4.2 9423
4 ex10-1.htm EX-10.1 79200
5 ex10-2.htm EX-10.2 12306
6 ex10-2_001.jpg GRAPHIC 4389
10 ex4-2_001.jpg GRAPHIC 403423
11 ex4-2_002.jpg GRAPHIC 340118
12 ex4-2_003.jpg GRAPHIC 456410
13 ex4-2_004.jpg GRAPHIC 493417
14 ex4-2_005.jpg GRAPHIC 404387
15 ex4-2_006.jpg GRAPHIC 416954
16 ex4-2_007.jpg GRAPHIC 380880
17 ex4-2_008.jpg GRAPHIC 77172
18 ex4-2_0090.jpg GRAPHIC 42190
19 ex4-2_010.jpg GRAPHIC 99972
20 ex4-2_011.jpg GRAPHIC 51863
  Complete submission text file 0001493152-23-024277.txt   4847802

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ppcb-20230629.xsd EX-101.SCH 3012
8 XBRL LABEL FILE ppcb-20230629_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE ppcb-20230629_pre.xml EX-101.PRE 22357
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3109
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 330662986 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54878 | Film No.: 231082960
SIC: 2834 Pharmaceutical Preparations